Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 EUR | -3.29% | -6.22% | -26.48% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.48% | 532M | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+46.00% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva's Chikungunya Vaccine Candidate Triggers Equal Immune Responses in Lot-to-Lot Late-Stage Study